| Revenue | DKK 336K | -40% |
| EBITDA | DKK 336K | -40% |
| Net profit | DKK 264K | -40% |
| Total assets | DKK 416K | -38% |
| Equity | DKK 317K | -34% |
| Employees | — | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38 | 100 | 230 | 124 | 184 | 316 | 248 | 232 | 561 | 336 |
| Staff expenses | -2 | -1 | -26 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 36 | 99 | 204 | 124 | 184 | 316 | 248 | 232 | 561 | 336 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 36 | 99 | 204 | 124 | 184 | 316 | 248 | 232 | 561 | 336 |
| Net financials | 0 | 9 | -24 | -1 | 51 | -50 | -53 | 45 | 21 | 4 |
| Profit before tax | 36 | 108 | 180 | 123 | 236 | 266 | 195 | 277 | 583 | 340 |
| Tax | 8 | 24 | 40 | 34 | 53 | 59 | 44 | 61 | 141 | 76 |
| Net profit | 28 | 83 | 140 | 89 | 182 | 207 | 151 | 215 | 442 | 264 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 36 | 111 | 208 | 171 | 393 | 350 | 343 | 367 | 673 | 416 |
| Equity | 28 | 111 | 192 | 161 | 343 | 290 | 241 | 316 | 483 | 317 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 0 | 17 | 11 | 50 | 60 | 102 | 51 | 190 | 100 |
| Total debt | 8 | 0 | 17 | 11 | 50 | 60 | 102 | 51 | 190 | 100 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2015 | — | — |
LM Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Speciallægeselskabet Groblos ApS | Company | 50.0% | 50.0% | 2020 |
Veragnes ApS | Company | 50.0% | 50.0% | 2020 |
Apuaa Holding ApS | Company | 20.0% | 20.0% | 2019 |
| Person | Role here | Other companies |
|---|---|---|
| Søren Solborg Bjerrum | Management | 0 companies |
| Lasse Malmqvist | Management | 0 companies |